Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD | MicrobiomeTrials← Back to trialsNCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
ENROLLING_BY_INVITATIONPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-08Est. Completion: 2029-03-02
Enrollment target: 645 participants Locations- Site 012, Lancaster, California, United States
- Site 007, Kissimmee, Florida, United States
- Site 035, Marrero, Louisiana, United States
- Site 025, Providence, Rhode Island, United States
- Study Site 002, San Antonio, Texas, United States
- Site 008, Southlake, Texas, United States
- Site 019, Tacoma, Washington, United States
- Site 103, Rosario, Santa Fe Province, Argentina
- Site 208, Concord, New South Wales, Australia
- Site 206, South Brisbane, Queensland, Australia
- Site 463, Linz, Upper Austria, Austria
- Site 461, Salzburg, Austria
- Site 473, Leuven, Flemish Brabant, Belgium
- Site 471, Ghent, Oost-Vlaanderen, Belgium
- Site 128, Santo André, São Paulo, Brazil
- Site 153, Osorno, Los Lagos Region, Chile
- Site 152, Santiago, Santiago Metropolitan, Chile
- Site 531, Brno, Czechia
- Site 584, Kutaisi, Georgia
- Site 589, Marneuli, Georgia
Other microbiome trials you might be interested in
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active…
Canoga Park, United StatesEst. completion Jun 2027
Ulcerative ColitisPrimary Sclerosing Cholangitis
In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlei…
Tehran, IranCompleted May 10, 2025
Site 581, Tbilisi, GeorgiaSite 588, Tbilisi, GeorgiaSite 583, Tbilisi, GeorgiaSite 586, Tbilisi, GeorgiaSite 582, Tbilisi, GeorgiaSite 587, Tbilisi, GeorgiaSite 603, Ulm, GermanySite 634, Athens, GreeceSite 651, Budapest, HungarySite 652, Székesfehérvár, HungarySite 673, Legnano, Milan, ItalySite 672, Negrar, Verona, ItalySite 424, Amman, JordanSite 421, Amman, JordanSite 422, Irbid, JordanSite 423, Irbid, JordanSite 174, Saltillo, Coahuila, MexicoSite 175, Celaya, Guanajuato, MexicoSite 173, Tlajomulco de Zúñiga, Jalisco, MexicoSite 711, Chisinau, MoldovaSite 712, Chisinau, MoldovaSite 753, Bydgoszcz, PolandSite 732, Bydgoszcz, PolandSite 748, Krakow, PolandSite 750, Kłodzko, PolandSite 746, Lodz, PolandSite 743, Opole, PolandSite 740, Poznan, PolandSite 736, Rzeszów, PolandSite 744, Sopot, PolandSite 737, Szczecin, PolandSite 752, Tychy, PolandSite 754, Warsaw, PolandSite 731, Warsaw, PolandSite 738, Wroclaw, PolandSite 734, Wroclaw, PolandSite 747, Wroclaw, PolandSite 742, Wroclaw, PolandSite 781, Bucharest, RomaniaSite 788, Timișoara, RomaniaSite 802, Belgrade, SerbiaSite 803, Belgrade, SerbiaSite 807, Belgrade, SerbiaSite 801, Zrenjanin, SerbiaSite 823, Bratislava, SlovakiaSite 822, Košice, SlovakiaSite 824, Prešov, SlovakiaSite 353, Wŏnju, Gangwon-do, South KoreaSite 357, Busan, South KoreaSite 354, Daegu, South KoreaSite 361, Daegu, South KoreaSite 355, Daejeon, South KoreaSite 356, Seoul, South KoreaSite 362, Seoul, South KoreaSite 360, Seoul, South KoreaSite 394, Changhua, TaiwanSite 392, Chiayi City, TaiwanSite 395, Kaohsiung City, TaiwanSite 396, Taichung, TaiwanSite 391, Taipei, TaiwanSite 906, Ivano-Frankivsk, UkraineSite 902, Kyiv, UkraineSite 904, Kyiv, UkraineSite 913, Kyiv, UkraineSite 911, Kyiv, UkraineSite 903, Kyiv, UkraineSite 901, Lutsk, UkraineSite 909, Lviv, UkraineSite 914, Poltava, UkraineSite 908, Vinnytsia, UkraineSite 907, Vinnytsia, Ukraine